4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic acid

In the synthesis, the amino group on the pyrimidine-pyridine moiety undergoes amide or urea-type coupling reactions with other intermediates, allowing construction of the extended molecular framework characteristic of Nilotinib. This compound provides both the aromatic system for kinase binding and the functional handle (carboxylic acid) required for subsequent reactions to install the remaining substituents, ultimately yielding the tyrosine kinase inhibitor with high specificity. Its structural features—particularly the methyl-substituted benzoic acid and the pyridine-pyrimidine linkage—are crucial for the drug’s binding affinity and selectivity for BCR-ABL. Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic acid is a key intermediate in the synthesis of Nilotinib, serving as the aryl-amino acid building block that forms the central core of the molecule.